Hypermutation in the E2 gene of human papillomavirus type 16 in cervical intraepithelial neoplasia

Journal of Medical Virology

Volumn 87, Issue 10, 2015, Pages 1754-1760

  Kukimoto, Iwao ^a   Mori, Seiichiro ^a   Aoyama, Satoru ^b   Wakae, Kousho ^b   Muramatsu, Masamichi ^b   Kondo, Kazunari ^c  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

Author keywords

APOBEC protein; Cervical intraepithelial neoplasia; Human papillomavirus; Hypermutation

Indexed keywords

ADENINE; HYDROLASE; PROTEIN APOBEC3; THYMINE; UNCLASSIFIED DRUG; APOBEC3 PROTEIN, HUMAN; CYTOSINE DEAMINASE; DNA BINDING PROTEIN; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; DNA DENATURATION; E2 GENE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HYPERMUTATION; MIDDLE AGED; NONHUMAN; POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA IN SITU; VIRUS GENE; VIRUS GENOME; GENETICS; MUTATION; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTOSINE DEAMINASE; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; MUTATION; ONCOGENE PROTEINS, VIRAL; POLYMERASE CHAIN REACTION;

EID: 84938551679     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24215     Document Type: Article

References (15)

1. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, Boyault S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils R, Eyfjord JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T, Imbeaud S, Imielinski M, Jager N, Jones DT, Jones D, Knappskog S, Kool M, Lakhani SR, Lopez-Otin C, Martin S, Munshi NC, Nakamura H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson JV, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague JW, Totoki Y, Tutt AN, Valdes-Mas R, van Buuren MM, van 't Veer L, Vincent-Salomon A, Waddell N, Yates LR, Zucman-Rossi J, Futreal PA, McDermott U, Lichter P, Meyerson M, Grimmond SM, Siebert R, Campo E, Shibata T, Pfister SM, Campbell PJ, Stratton MR. 2013. Signatures of mutational processes in human cancer. Nature 500:415-421.
2. Burns MB, Temiz NA, Harris RS. 2013. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet 45:977-983.
3. Conticello SG 2008. The AID/APOBEC family of nucleic acid mutators. Genome Biol 9:229.
4. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N, Bosch FX. 2010. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 11:1048-1056.
5. Henderson S, Chakravarthy A, Su X, Boshoff C, Fenton TR. 2014. APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. Cell Rep 7:1833-1841.
6. Johannsen E, Lambert PF. 2013. Epigenetics of human papillomaviruses. Virology 445:205-212.
7. Kondo K, Uenoyama A, Kitagawa R, Tsunoda H, Kusumoto-Matsuo R, Mori S, Ishii Y, Takeuchi T, Kanda T, Kukimoto I. 2012. Genotype distribution of human papillomaviruses in Japanese women with abnormal cervical cytology. Open Virol J 6:277-283.
8. Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P, Kiezun A, Kryukov GV, Carter SL, Saksena G, Harris S, Shah RR, Resnick MA, Getz G, Gordenin DA. 2013. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet 45:970-976.
9. Stenglein MD, Burns MB, Li M, Lengyel J, Harris RS. 2010. APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol 17:222-229.
10. Vartanian JP, Guetard D, Henry M, Wain-Hobson S. 2008. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 320:230-233.
11. Vieira VC, Leonard B, White EA, Starrett GJ, Temiz NA, Lorenz LD, Lee D, Soares MA, Lambert PF, Howley PM, Harris RS. 2014. Human Papillomavirus E6 Triggers Upregulation of the Antiviral and Cancer Genomic DNA Deaminase APOBEC3B. MBio 5:e02234-14.
12. Wang Z, Wakae K, Kitamura K, Aoyama S, Liu G, Koura M, Monjurul AM, Kukimoto I, Muramatsu M. 2014. APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation. J Virol 88:1308-1317.
13. Warren CJ, Xu T, Guo K, Griffin LM, Westrich JA, Lee D, Lambert PF, Santiago ML, Pyeon D. 2015. APOBEC3A Functions as a Restriction Factor of Human Papillomavirus. J Virol 89:688-702.
14. Xue Y, Lim D, Zhi L, He P, Abastado JP, Thierry F. 2012. Loss of HPV16 E2 Protein Expression Without Disruption of the E2 ORF Correlates with Carcinogenic Progression. Open Virol J 6:163-172.
15. zur Hausen H 2002. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2:342-350.